Cutaneous melanoma (CM) is a malignant tumor formed from pigment-producing cells
called melanocytes. It is one of the most aggressive and fatal forms of skin malignancy. In …

Management of the melanoma patient is a complex and evolving subject. Plastic surgeons
should be aware of the recent changes in the field. Excisional biopsy remains the gold …

Background A gene expression profile (GEP) test able to accurately identify risk of
metastasis for patients with cutaneous melanoma has been clinically validated. Objective …

Cutaneous melanoma is responsible for the vast majority of skin cancer-related deaths in
the United States. Known risk factors include genetic defects, environmental exposures, and …

Purpose Cutaneous melanoma incidence is increasing. Most new cases are thin (≤ 1 mm)
with favorable prognoses, but survival is nonetheless variable. Our aim was to investigate …

A number of oncogenic driver mutations have been identified in melanocytic nevi and
melanoma, but translocations also play a role in tumorigenesis and provide potential …

Melanoma is the most aggressive form of skin cancer and, if spread outside the epidermis,
has a dismal prognosis. Before the approval of the anti-cytotoxic T lymphocyte-associated …

Therapeutic vaccines to induce anti-tumor CD8 T cells have been used in clinical trials for
advanced melanoma patients, but the clinical response rate and overall survival time have …

Cutaneous melanoma arises from the malignant transformation of skin melanocytes; its
incidence and mortality have been increasing steadily over the last 50 years, now …

Objectives This study aimed to assess the knowledge of risk factors and warning symptoms
and attitude towards gastric cancer screening among the general population in China …